Bénédicte Dubois

16.5k total citations · 2 hit papers
84 papers, 4.9k citations indexed

About

Bénédicte Dubois is a scholar working on Immunology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Bénédicte Dubois has authored 84 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Immunology, 31 papers in Pathology and Forensic Medicine and 16 papers in Molecular Biology. Recurrent topics in Bénédicte Dubois's work include Multiple Sclerosis Research Studies (29 papers), T-cell and B-cell Immunology (19 papers) and Immunotherapy and Immune Responses (10 papers). Bénédicte Dubois is often cited by papers focused on Multiple Sclerosis Research Studies (29 papers), T-cell and B-cell Immunology (19 papers) and Immunotherapy and Immune Responses (10 papers). Bénédicte Dubois collaborates with scholars based in Belgium, United States and United Kingdom. Bénédicte Dubois's co-authors include Ghislain Opdenakker, Inge Nelissen, Philippe E. Van den Steen, Raymond A. Dwek, Pauline M. Rudd, An Goris, Raf Sciot, Wim Robberecht, Paul Rutgeerts and Maja Noman and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Bénédicte Dubois

82 papers receiving 4.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Biochemistry and Molecular Biology of Gelatinase B or Matrix Metalloproteinase-9 (MMP-9)

2002 789 citations Bénédicte Dubois, Inge Nelissen et al. profile →
Progressive Multifocal Leukoencephalopathy after Natalizumab Therapy for Crohn's Disease

2005 789 citations Bénédicte Dubois et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bénédicte Dubois Belgium	30	1.4k	1.4k	1.1k	1.1k	992	84	4.9k
Thomas F.E. Barth Germany	46	1.7k 1.2×	2.4k 1.7×	1.6k 1.4×	2.0k 1.9×	925 0.9×	236	7.0k
Michel Peuchmaur France	49	1.9k 1.3×	1.1k 0.8×	2.0k 1.8×	1.5k 1.4×	637 0.6×	189	7.6k
Victor M. Elner United States	48	1.9k 1.4×	620 0.4×	2.6k 2.3×	1.4k 1.2×	660 0.7×	246	9.7k
Su-Ming Hsu United States	33	1.2k 0.8×	1.2k 0.9×	1.5k 1.3×	1.5k 1.4×	444 0.4×	74	5.5k
Christine Bodemer France	47	2.0k 1.4×	1.3k 0.9×	2.2k 2.0×	683 0.6×	370 0.4×	309	8.2k
Shigeo Mori Japan	46	1.7k 1.2×	2.4k 1.7×	2.4k 2.1×	3.4k 3.1×	601 0.6×	213	7.9k
Birgitta Sander Sweden	37	1.4k 1.0×	1.5k 1.0×	1.0k 0.9×	1.3k 1.2×	262 0.3×	141	4.4k
Isao Kitajima Japan	42	1.2k 0.9×	368 0.3×	2.1k 1.9×	607 0.6×	561 0.6×	182	5.7k
Sudeepta Aggarwal United States	23	3.6k 2.6×	561 0.4×	1.6k 1.4×	1.4k 1.2×	494 0.5×	46	8.5k
Edward P. Amento United States	43	1.8k 1.3×	1.2k 0.9×	2.3k 2.1×	1.2k 1.1×	1.2k 1.2×	78	8.2k

Countries citing papers authored by Bénédicte Dubois

Since Specialization

Citations

This map shows the geographic impact of Bénédicte Dubois's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bénédicte Dubois with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bénédicte Dubois more than expected).

Fields of papers citing papers by Bénédicte Dubois

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bénédicte Dubois. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bénédicte Dubois. The network helps show where Bénédicte Dubois may publish in the future.

Co-authorship network of co-authors of Bénédicte Dubois

This figure shows the co-authorship network connecting the top 25 collaborators of Bénédicte Dubois. A scholar is included among the top collaborators of Bénédicte Dubois based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bénédicte Dubois. Bénédicte Dubois is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dubois, Bénédicte, et al.. (2024). Single center, real-world retrospective study of CAR-T cell therapy for relapsed/refractory large B-cell lymphoma beyond second line: five-year results at the University Hospitals Leuven. Acta Clinica Belgica. 79(4). 276–284. 2 indexed citations

Matthys, Patrick, et al.. (2024). CHIT1 at diagnosis predicts faster disability progression and reflects early microglial activation in multiple sclerosis. Nature Communications. 15(1). 5013–5013. 6 indexed citations

Goris, An, et al.. (2023). A targeted sequencing extension for transcript genotyping in single-cell transcriptomics. Life Science Alliance. 6(11). e202301971–e202301971. 3 indexed citations

Laenen, Lies, Kim C. M. van der Elst, Dietmar Rudolf Thal, et al.. (2022). Antiviral treatment with fluoxetine for rituximab‐associated chronic echovirus 13 meningoencephalitis and myofasciitis. European Journal of Neurology. 29(10). 3117–3123. 4 indexed citations

Cassiman, Cathérine, et al.. (2022). Optical coherence tomography as a prognostic tool for disability progression in MS: a systematic review. Journal of Neurology. 270(2). 1178–1186. 6 indexed citations

Vandebergh, Marijne, et al.. (2022). Body Mass Index, Interleukin-6 Signaling and Multiple Sclerosis: A Mendelian Randomization Study. Frontiers in Immunology. 13. 834644–834644. 21 indexed citations

Smets, Ide, Teresa Prezzemolo, Tania Mitera, et al.. (2021). Treatment-Induced BAFF Expression and B Cell Biology in Multiple Sclerosis. Frontiers in Immunology. 12. 676619–676619. 8 indexed citations

Lagou, Vasiliki, Josselyn E. Garcia‐Perez, Ide Smets, et al.. (2018). Genetic Architecture of Adaptive Immune System Identifies Key Immune Regulators. Cell Reports. 25(3). 798–810.e6. 31 indexed citations

Schneeberger, Achim, Suzanne Hendrix, Markus Mandler, et al.. (2015). RESULTS FROM A PHASE II STUDY TO ASSESS THE CLINICAL AND IMMUNOLOGICAL ACTIVITY OF AFFITOPE® AD02 IN PATIENTS WITH EARLY ALZHEIMER’S DISEASE. The Journal of Prevention of Alzheimer s Disease. 2(2). 1–12. 32 indexed citations

10.

Calster, Joachim Van, et al.. (2014). Characteristic callosal involvement in Susac’s syndrome. Acta Neurologica Belgica. 115(3). 395–396. 6 indexed citations

11.

Debray, Sarah, Valérie Race, Gert Matthijs, et al.. (2013). Frequency of C9orf72 repeat expansions in amyotrophic lateral sclerosis: a Belgian cohort study. Neurobiology of Aging. 34(12). 2890.e7–2890.e12. 30 indexed citations

12.

Goris, An, Andrew Walton, Maria Ban, et al.. (2008). A Taqman assay for high‐throughput genotyping of the multiple sclerosis‐associated HLA‐DRB1*1501 allele. Tissue Antigens. 72(4). 401–403. 23 indexed citations

13.

Wijmeersch, Bart Van, Ben Sprangers, Bénédicte Dubois, Mark Waer, & An Billiau. (2008). Autologous and allogeneic hematopoietic stem cell transplantation for Multiple Sclerosis: Perspective on mechanisms of action. Journal of Neuroimmunology. 197(2). 89–98. 17 indexed citations

14.

Venken, Koen, Niels Hellings, Karen Hensen, et al.. (2006). Secondary progressive in contrast to relapsing: remitting multiple sclerosis patients show a normal CD4+CD25+ regulatory T cell function and FOXP3 expression. Journal of Neuroimmunology. 178. 196–196. 7 indexed citations

15.

Suppiah, Vijayaprakash, An Goris, Iraide Alloza, et al.. (2005). Polymorphisms in the interleukin‐4 and IL‐4 receptor genes and multiple sclerosis: a study in Spanish‐Basque, Northern Irish and Belgian populations. International Journal of Immunogenetics. 32(6). 383–388. 29 indexed citations

16.

Roxburgh, Richard & Bénédicte Dubois. (2003). The multiple sclerosis severity score. Multiple Sclerosis Journal. 9. 1 indexed citations

17.

Dubois, Bénédicte, et al.. (2001). Serum MMP-9 in primary progressive multiple sclerosis patients treated with interferon-beta-1a. Multiple Sclerosis Journal. 7. 1 indexed citations

18.

Dubois, Bénédicte, R Gonsette, Chris Dillen, & Alfons Billiau. (2001). Efficacy of a novel non-cardiotoxic aza-anthracenedione (BBR2778) in acute EAE. Multiple Sclerosis Journal. 7. 4 indexed citations

19.

Wuyts, Anja, Chris Dillen, Bénédicte Dubois, et al.. (2000). In Vivo Neutrophil Recruitment by Granulocyte Chemotactic Protein-2 Is Assisted by Gelatinase B/MMP-9 in the Mouse. Journal of Interferon & Cytokine Research. 20(7). 667–674. 70 indexed citations

20.

Fiten, Pierre, Koen Vandenbroeck, Bénédicte Dubois, et al.. (1999). Microsatellite polymorphisms in the gene promoter of monocyte chemotactic protein-3 and analysis of the association between monocyte chemotactic protein-3 alleles and multiple sclerosis development. Journal of Neuroimmunology. 95(1-2). 195–201. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact